143 related articles for article (PubMed ID: 16810202)
41. Histone deacetylase inhibitors upregulate plakoglobin expression in bladder carcinoma cells and display antineoplastic activity in vitro and in vivo.
Canes D; Chiang GJ; Billmeyer BR; Austin CA; Kosakowski M; Rieger-Christ KM; Libertino JA; Summerhayes IC
Int J Cancer; 2005 Feb; 113(5):841-8. PubMed ID: 15499627
[TBL] [Abstract][Full Text] [Related]
42. Two serologic markers to monitor the engraftment, growth, and treatment response of human leukemias in severe combined immunodeficient mice.
Arguello F; Sterry JA; Zhao YZ; Alexander MR; Shoemaker RH; Cohen HJ
Blood; 1996 May; 87(10):4325-32. PubMed ID: 8639792
[TBL] [Abstract][Full Text] [Related]
43. Establishment of reproducible xenotransplantation model of T cell acute lymphoblastic leukemia in NOD/SCID mice.
Wang D; Wang N; Zhang Y; Ma S; Geng Z; Zhou P; Zhou J; Huang L
J Huazhong Univ Sci Technolog Med Sci; 2012 Aug; 32(4):511-516. PubMed ID: 22886962
[TBL] [Abstract][Full Text] [Related]
44. Efficacy of a CD22-targeted antibody-saporin conjugate in a xenograft model of precursor-B cell acute lymphoblastic leukemia.
Kato J; Satake N; O'Donnell RT; Abuhay M; Lewis C; Tuscano JM
Leuk Res; 2013 Jan; 37(1):83-8. PubMed ID: 23040543
[TBL] [Abstract][Full Text] [Related]
45. Development of potential antitumor agents. Synthesis and biological evaluation of a new set of sulfonamide derivatives as histone deacetylase inhibitors.
Bouchain G; Leit S; Frechette S; Khalil EA; Lavoie R; Moradei O; Woo SH; Fournel M; Yan PT; Kalita A; Trachy-Bourget MC; Beaulieu C; Li Z; Robert MF; MacLeod AR; Besterman JM; Delorme D
J Med Chem; 2003 Feb; 46(5):820-30. PubMed ID: 12593661
[TBL] [Abstract][Full Text] [Related]
46. Molecule of the month. Vorinostat.
Drug News Perspect; 2006; 19(6):352. PubMed ID: 16971971
[No Abstract] [Full Text] [Related]
47. Engraftment of low numbers of pediatric acute lymphoid and myeloid leukemias into NOD/SCID/IL2Rcγnull mice reflects individual leukemogenecity and highly correlates with clinical outcome.
Woiterski J; Ebinger M; Witte KE; Goecke B; Heininger V; Philippek M; Bonin M; Schrauder A; Röttgers S; Herr W; Lang P; Handgretinger R; Hartwig UF; André MC
Int J Cancer; 2013 Oct; 133(7):1547-56. PubMed ID: 23526331
[TBL] [Abstract][Full Text] [Related]
48. Effect of the histone deacetylase inhibitor depsipeptide on B-cell differentiation in both TEL-AML1-positive and negative childhood acute lymphoblastic leukemia.
Stams WA; den Boer ML; Beverloo HB; Kazemier KM; van Wering ER; Janka-Schaub GE; Pieters R
Haematologica; 2005 Dec; 90(12):1697-9. PubMed ID: 16330447
[TBL] [Abstract][Full Text] [Related]
49. Favorable neuroblastoma genes and molecular therapeutics of neuroblastoma.
Tang XX; Robinson ME; Riceberg JS; Kim DY; Kung B; Titus TB; Hayashi S; Flake AW; Carpentieri D; Ikegaki N
Clin Cancer Res; 2004 Sep; 10(17):5837-44. PubMed ID: 15355914
[TBL] [Abstract][Full Text] [Related]
50. Targeting non-oncogene ROS pathway by alantolactone in B cell acute lymphoblastic leukemia cells.
Xu X; Huang L; Zhang Z; Tong J; Mi J; Wu Y; Zhang C; Yan H
Life Sci; 2019 Jun; 227():153-165. PubMed ID: 31004657
[TBL] [Abstract][Full Text] [Related]
51. Malignant stem cells in childhood acute lymphoblastic leukemia: the stem cell concept revisited.
Vormoor HJ
Cell Cycle; 2009 Apr; 8(7):996-9. PubMed ID: 19270513
[TBL] [Abstract][Full Text] [Related]
52. The central nervous system microenvironment influences the leukemia transcriptome and enhances leukemia chemo-resistance.
Gaynes JS; Jonart LM; Zamora EA; Naumann JA; Gossai NP; Gordon PM
Haematologica; 2017 Apr; 102(4):e136-e139. PubMed ID: 28034988
[No Abstract] [Full Text] [Related]
53. Recombinant human CD19L-sTRAIL effectively targets B cell precursor acute lymphoblastic leukemia.
Uckun FM; Myers DE; Qazi S; Ozer Z; Rose R; D'Cruz OJ; Ma H
J Clin Invest; 2015 Mar; 125(3):1006-18. PubMed ID: 25621496
[TBL] [Abstract][Full Text] [Related]
54. Engraftment of human T-cell acute lymphoblastic leukemia in immunodeficient NOD/SCID mice which have been preconditioned by injection of human cord blood.
Dialynas DP; Shao L; Billman GF; Yu J
Stem Cells; 2001; 19(5):443-52. PubMed ID: 11553853
[TBL] [Abstract][Full Text] [Related]
55. Obinutuzumab (GA101) compared to rituximab significantly enhances cell death and antibody-dependent cytotoxicity and improves overall survival against CD20(+) rituximab-sensitive/-resistant Burkitt lymphoma (BL) and precursor B-acute lymphoblastic leukaemia (pre-B-ALL): potential targeted therapy in patients with poor risk CD20(+) BL and pre-B-ALL.
Awasthi A; Ayello J; Van de Ven C; Elmacken M; Sabulski A; Barth MJ; Czuczman MS; Islam H; Klein C; Cairo MS
Br J Haematol; 2015 Dec; 171(5):763-75. PubMed ID: 26471982
[TBL] [Abstract][Full Text] [Related]
56. [Therapeutic strategies for childhood high-risk acute lymphoblastic leukemia].
Lu XT
Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Apr; 45(2):327-32. PubMed ID: 23591360
[TBL] [Abstract][Full Text] [Related]
57. The sequence of application of methotrexate and histone deacetylase inhibitors determines either a synergistic or an antagonistic response in childhood acute lymphoblastic leukemia cells.
Bastian L; Einsiedel HG; Henze G; Seeger K; Shalapour S
Leukemia; 2011 Feb; 25(2):359-61. PubMed ID: 21072050
[No Abstract] [Full Text] [Related]
58. mTOR inhibitors are synergistic with methotrexate: an effective combination to treat acute lymphoblastic leukemia.
Teachey DT; Sheen C; Hall J; Ryan T; Brown VI; Fish J; Reid GS; Seif AE; Norris R; Chang YJ; Carroll M; Grupp SA
Blood; 2008 Sep; 112(5):2020-3. PubMed ID: 18544682
[TBL] [Abstract][Full Text] [Related]
59. Successful engraftment of human acute lymphoblastic leukemia cells in NOD/SCID mice via intrasplenic inoculation.
Wang N; Huang L; Wang D; Wang J; Jiang L; Zhou K; Yang Y; Xu D; Zhou J
Cancer Biol Ther; 2012 Oct; 13(12):1158-64. PubMed ID: 22892848
[TBL] [Abstract][Full Text] [Related]
60. CD9 blockade suppresses disease progression of high-risk pediatric B-cell precursor acute lymphoblastic leukemia and enhances chemosensitivity.
Leung KT; Zhang C; Chan KYY; Li K; Cheung JTK; Ng MHL; Zhang XB; Sit T; Lee WYW; Kang W; To KF; Yu JWS; Man TKF; Wang H; Tsang KS; Cheng FWT; Lam GKS; Chow TW; Leung AWK; Leung TF; Yuen PMP; Ng PC; Li CK
Leukemia; 2020 Mar; 34(3):709-720. PubMed ID: 31624373
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
